bluebird bio News

J.P. Morgan Maintains Bluebird Bio(BLUE.US) With Hold Rating

Moomoo NewsOct 10 07:31 ET

Bluebird Bio's Restructuring Efforts and Financial Outlook: A Cautious Hold Rating

TipRanksSep 27 13:18 ET

Bluebird Bio Is Maintained at Equal-Weight by Wells Fargo

Dow JonesSep 25 12:46 ET

Bluebird Bio Analyst Ratings

BenzingaSep 25 12:39 ET

Wells Fargo Maintains Bluebird Bio(BLUE.US) With Hold Rating, Cuts Target Price to $2

Moomoo NewsSep 25 06:32 ET

Maintaining Hold on Bluebird Bio: Balancing LYFGENIA's Promise Against Financial and Operational Hurdles

TipRanksSep 25 05:49 ET

Barclays Maintains Bluebird Bio(BLUE.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsSep 25 05:33 ET

Analysts Are Bullish on Top Healthcare Stocks: Bluebird Bio (BLUE), Immunic (IMUX)

TipRanksSep 25 05:07 ET

William Blair Maintains Bluebird Bio(BLUE.US) With Hold Rating

Moomoo NewsSep 24 11:32 ET

William Blair Reaffirms Their Hold Rating on Bluebird Bio (BLUE)

TipRanksSep 24 11:28 ET

Bluebird Bio Analyst Ratings

BenzingaSep 16 08:27 ET

J.P. Morgan Maintains Bluebird Bio(BLUE.US) With Hold Rating

Moomoo NewsAug 19 08:31 ET

Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), ImmunityBio (IBRX) and Neurocrine (NBIX)

TipRanksAug 19 08:15 ET

What 4 Analyst Ratings Have To Say About Bluebird Bio

BenzingaAug 15 16:03 ET

RBC Capital Maintains Bluebird Bio(BLUE.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsAug 15 11:32 ET

Bluebird Bio Price Target Maintained With a $4.00/Share by RBC Capital

Dow JonesAug 15 11:03 ET

BofA Securities Maintains Bluebird Bio(BLUE.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsAug 15 09:31 ET

A Quick Look at Today's Ratings for Bluebird Bio(BLUE.US), With a Forecast Between $3 to $4

Moomoo NewsAug 15 09:02 ET

Bluebird Bio Analyst Ratings

BenzingaAug 15 06:54 ET

Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)

TipRanksAug 15 06:33 ET